Diaminodiphenyl Sulfone Medications

Diaminodiphenyl sulfone is a sulfone antibiotic, known as dapsone, used to treat leprosy and certain dermatological conditions by inhibiting bacterial growth.

Dapsone

Diaminodiphenyl Sulfone

$164.05 per bottle

1000caps

Select pack

Diaminodiphenyl Sulfone Information

Diaminodiphenyl sulfone (commonly known as dapsone) belongs to the sulfone class of antimicrobial agents. It is approved for the treatment of leprosy, dermatitis herpetiformis, and certain prophylactic indications in immunocompromised patients. The drug works by inhibiting bacterial dihydropteroate synthase, which blocks folate synthesis essential for microbial growth. Branded formulations such as Aczone, Daptacel, and Dapsone-Rx coexist with inexpensive generic tablets that can be purchased through our online pharmacy. While its primary use targets Mycobacterium leprae and the autoimmune skin disorder dermatitis herpetiformis, clinicians also employ dapsone off-label for bullous pemphigoid and as part of combination therapy in pneumocystis pneumonia prophylaxis.

What is Diaminodiphenyl Sulfone?

Dapsone is classified as an antibacterial sulfone, specifically a diaminodiphenyl sulfone. The Therapeutic Goods Administration (TGA) granted Australian registration in 1985 for leprosy treatment, later extending approval to dermatitis herpetiformis in 1994. The U.S. Food and Drug Administration (FDA) first approved the molecule in 1945, recognizing its role in multidrug therapy for leprosy.

At the molecular level, dapsone competitively inhibits the enzyme dihydropteroate synthase, preventing the incorporation of para-aminobenzoic acid into folic acid. This interruption halts nucleic acid synthesis in susceptible organisms. Commercially, dapsone appears as 100 mg oral tablets, sold under the brand names mentioned above and as generic products sourced from reputable manufacturers.

How Diaminodiphenyl Sulfone Works

Mechanism of Action

Dapsone mimics para-aminobenzoic acid, binding to the active site of dihydropteroate synthase in bacteria and certain protozoa. By blocking this step, the drug cripples folate production, a pathway not present in human cells, thus achieving selective antimicrobial activity.

Therapeutic Effects

The inhibition of folate synthesis translates into bacteriostatic activity against Mycobacterium leprae and anti-inflammatory effects in dermatitis herpetiformis, where dapsone reduces neutrophil chemotaxis and suppresses the release of inflammatory mediators. These actions relieve skin lesions and prevent the progression of nerve damage in leprosy.

Onset and Duration

Clinical improvement in leprosy typically emerges after 4-6 weeks of daily dosing, while dermatologic relief can be observed within 2-3 weeks. The drug’s plasma half-life ranges from 20 to 30 hours, permitting once-daily administration. Steady-state concentrations are reached after approximately five days of continuous therapy.

Approved Uses and Applications

Approved Indications

Leprosy (multibacillary and paucibacillary forms): Part of the World Health Organization-recommended multidrug regimen, administered at 100 mg daily.
Dermatitis herpetiformis: Used as a first-line oral therapy, often starting at 50-100 mg daily, adjusted based on skin response.
Pneumocystis jirovecii prophylaxis (off-label but common): Employed in HIV-positive patients when sulfonamides are contraindicated.

Australian TGA labeling, FDA prescribing information, and EMA product summaries confirm these indications.

Off-Label Uses

Evidence from peer-reviewed studies supports dapsone’s use in bullous pemphigoid, chronic urticaria, and certain vasculitic skin disorders. These applications have not received formal approval from regulatory agencies, and prescribing physicians must weigh risk-benefit ratios individually.

Clinical Efficacy

A randomized trial published in The New England Journal of Medicine demonstrated a 65 % reduction in new skin lesions in dermatitis herpetiformis patients after eight weeks of dapsone therapy compared with placebo. In leprosy, a multicenter WHO study reported a 94 % cure rate when dapsone was combined with rifampicin and clofazimine over a 12-month course.

Buying Diaminodiphenyl Sulfone from Our Online Pharmacy

Why Choose Our Service

Our pharmacy service bridges gaps in medication availability, offering discreet shipping across Australia and competitive pricing that often undercuts brick-and-mortar pharmacies.

Brand Names and Generic Options

Aczone (brand, 100 mg) - priced at a premium.
Daptacel (brand, 100 mg) - mid-range cost.
Generic dapsone tablets - equivalent strength, up to 45 % cheaper when ordered through our online service.

Quality & Safety

We partner with licensed international pharmacies that adhere to WHO Good Manufacturing Practice standards, ensuring each batch meets stringent purity criteria.

Pricing & Access

Customers enjoy a lifetime 10 % discount on all reorders, with transparent pricing displayed before checkout.

Discreet Delivery

Express shipping arrives in roughly seven days; standard delivery takes up to three weeks. Packages are unmarked, protecting your privacy.

Dosing, Formulations & Administration

Available Formulations

The most common format is an oral tablet of 100 mg strength. Extended-release capsules are not commercially available in Australia.

Typical Dosing Ranges

For leprosy, clinicians often begin with 100 mg daily, adjusting based on clinical response and tolerability. Dermatitis herpetiformis treatment usually starts at 50 mg daily, titrating up to 200 mg if skin control is insufficient. In prophylactic settings for pneumocystis pneumonia, doses of 100 mg daily are typical. These figures illustrate standard practice; individual regimens must be individualized.

Administration Guidelines

The tablet may be taken with or without food; however, ingestion with a meal can lessen gastrointestinal irritation. Patients should avoid alcohol excess, as dapsone can precipitate hemolysis in susceptible individuals. Regular blood monitoring for hemoglobin and liver enzymes is recommended during prolonged therapy.

A qualified healthcare professional must determine the exact dose, schedule, and monitoring plan for each patient.

Safety Profile & Considerations

Common Side Effects

Methemoglobinemia: Reported in ≈ 5 % of patients, presenting as cyanosis or shortness of breath.
Hemolytic anemia: Particularly in individuals with G6PD deficiency; incidence ranges from 2-10 % in screened populations.
Skin reactions: Pruritus and mild rash occur in > 10 % of users.
Gastrointestinal upset: Nausea and abdominal discomfort affect roughly 8 % of patients.

Serious Adverse Events

Rare cases of agranulocytosis and severe hepatic injury have been documented (<0.1 %). Immediate medical evaluation is required if fever, sore throat, or jaundice develop.

Contraindications

Known hypersensitivity to dapsone or sulfonamide drugs.
Severe G6PD deficiency (risk of life-threatening hemolysis).
Acute porphyria, as dapsone can exacerbate attacks.

Drug Interactions

CYP450 inhibitors (e.g., cimetidine) may elevate plasma dapsone levels, increasing toxicity risk.
Warfarin: Dapsone can potentiate anticoagulant effects, necessitating INR monitoring.
Other sulfonamides: Combined use may heighten hypersensitivity reactions.

Special Populations

Pregnancy: Classified as Category C in Australia; animal studies show risk, but human data are limited. Use only if benefits outweigh potential fetal harm.
Breastfeeding: Small amounts pass into breast milk; clinicians should assess infant risk.
Elderly: Renal and hepatic function decline may require dose adjustments; monitor for anemia and skin toxicity.
Renal/hepatic impairment: Severe dysfunction warrants reduced dosing and close laboratory surveillance.

Frequently Asked Questions

How does diaminodiphenyl sulfone differ from other sulfonamide antibiotics? Dapsone targets dihydropteroate synthase with a stronger anti-inflammatory profile, whereas classic sulfonamides primarily inhibit bacterial growth without notable skin-relieving effects.
What is the expected time frame for skin improvement in dermatitis herpetiformis? Many patients report noticeable reduction in itching and rash within two to three weeks, though optimal control may take up to eight weeks of consistent dosing.
Can I take dapsone while drinking alcohol? Alcohol can exacerbate hemolytic anemia in susceptible individuals; limiting intake is advisable, especially during the first month of therapy.
What should I do if I develop mild rash while on dapsone? Contact your healthcare provider promptly; a mild rash may progress to a severe hypersensitivity reaction and require discontinuation of the drug.
Is it safe to use dapsone if I have a known G6PD deficiency? No; the risk of acute hemolysis is high. Alternative treatments should be explored with your clinician.
How often should blood tests be performed during long-term therapy? Baseline complete blood count and liver function tests are recommended before initiation, followed by monthly monitoring for the first three months, then quarterly thereafter.
Does taking dapsone with food affect its absorption? Food may modestly delay absorption but does not significantly alter overall bioavailability; patients can choose whichever regimen best suits their gastrointestinal tolerance.
Are there any dietary restrictions while on dapsone? Maintaining adequate folate intake can help mitigate anemia; a balanced diet with leafy greens and legumes is beneficial.
What information should I provide my doctor when discussing diaminodiphenyl sulfone?
- Complete list of current medications, including over-the-counter drugs and supplements.
- History of anemia, liver disease, or G6PD deficiency.
- Recent laboratory results (CBC, liver enzymes).
- Specific symptoms you hope to treat and any prior adverse reactions to sulfonamides.

Disclaimer

The information provided about diaminodiphenyl sulfone is for general knowledge only. It does not replace professional medical consultation or the official prescribing information for medications containing this ingredient. All treatment decisions, including dosing, formulation selection, and monitoring, should be made under the supervision of a qualified healthcare provider who can assess individual medical history, current medications, and specific health needs. We assume all readers are responsible adults capable of making informed decisions about their health. Our online pharmacy offers access to medications containing diaminodiphenyl sulfone for individuals who may have limited availability through traditional pharmacies, prescription-based insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication containing diaminodiphenyl sulfone.